# Glaukos Corporation

> glaucoma corneal retinal therapies

Business model and tags: B2B, Publicly traded, Hardware, Multi-product, Pharma & life sciences, Medical devices, International operations, Has in-house R&D

## About Glaukos Corporation

Develops novel therapies for glaucoma, corneal disorders, and retinal diseases, advancing patient care and treatment options globally in the ophthalmic market.

## Key facts

- **Industry**: Medical Equipment Manufacturing
- **Company size**: 1,001–5,000 employees
- **Headquarters**: Aliso Viejo, Alabama, United States
- **Founded**: 1998
- **Revenue**: $507M (FY2025, publicly reported)
- **Website**: [glaukos.com](https://www.glaukos.com/fr/)
- **LinkedIn**: [linkedin.com/company/glaukos-corporation](https://www.linkedin.com/company/glaukos-corporation)

## Glaukos Corporation at a glance

Glaukos Corporation is a B2B company in the Medical Equipment Manufacturing industry, headquartered in Aliso Viejo, Alabama, United States.

Glaukos Corporation was founded in 1998.

Glaukos Corporation has 1,001–5,000 employees.

Glaukos Corporation's revenue is $507M (FY2025, publicly reported).

## Frequently asked questions about Glaukos Corporation

### What is Glaukos Corporation's revenue?

Glaukos Corporation's revenue is $507M (FY2025, publicly reported).

### How many employees does Glaukos Corporation have?

Glaukos Corporation has 1,001–5,000 employees.

### Where is Glaukos Corporation headquartered?

Glaukos Corporation is headquartered in Aliso Viejo, Alabama, United States.

---

Company data compiled by Tamtam from public sources and Tamtam's own analysis. Figures marked as estimates are modelled, not reported.

Source: https://www.tamtam.ai/c/glaukos-corporation
